Skip to main content
Dhanuka Agritech Ltd. logo

Dhanuka Agritech Ltd. — Investor Relations & Filings

Ticker · DHANUKA ISIN · INE435G01025 LEI · 335800E4DLZIC7MSG125 BSE.NS Manufacturing
Open in API
Filings indexed 1,595 across all filing types
Latest filing 2024-11-25 Capital/Financing Update
Country IN India
Listing BSE.NS DHANUKA

About Dhanuka Agritech Ltd.

https://www.dhanuka.com/

Dhanuka Agritech Ltd. specializes in the manufacturing and marketing of a comprehensive range of crop protection solutions, including insecticides, herbicides, fungicides, and plant growth regulators. The company maintains strategic technical collaborations with several global chemical innovators to bring advanced formulations to the agricultural sector. Its product portfolio is supported by a robust research and development infrastructure and an extensive distribution network that facilitates the delivery of integrated pest management and soil health solutions. The organization focuses on enhancing agricultural productivity through the provision of high-quality inputs and technical advisory services. By leveraging a strong field force, it provides training and support to optimize crop yields and resource efficiency, ensuring the effective application of its diverse chemical and biological offerings.

Recent filings

Filing Released Lang Actions
Intimation of the signing of agreement by Dhanuka Agritech Limited with Bayer AG, Germany for the acquisition of active ingredients named " Iprovalicarb" and "Triadimenol"
Capital/Financing Update Classification · 95% confidence The document is an official intimation to stock exchanges (BSE and NSE) about the signing of an agreement by Dhanuka Agritech Limited with Bayer AG for the acquisition of active ingredients. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content is a detailed announcement of a business agreement related to acquisition of assets, not a full merger or takeover filing. It is not a full financial report, earnings release, or management discussion. The document is a regulatory announcement about a significant transaction but does not constitute a merger filing (MA) or a full M&A activity (TAR) filing. Given the nature of the announcement and the regulatory reference, this fits best under Capital/Financing Update (CAP) as it relates to acquisition of assets expanding business operations and involves a significant corporate transaction disclosed under SEBI regulations. The document length is under 5,000 characters, but it contains substantive disclosure details, not just a report publication announcement. Therefore, the classification is CAP with high confidence.
2024-11-25 English
Intimation of Analysts/Investors meet
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) informing them about the schedule of an Analyst / Institutional Investors Meet where the CFO will attend a conference. It is an intimation or announcement related to investor relations and does not contain financial data, report content, or voting results. It is a regulatory disclosure under SEBI regulations about an upcoming event. The document length is short (1501 characters) and it is clearly an announcement rather than a report or transcript. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2024-11-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) informing them about the schedule of an Analyst / Institutional Investors Meet where the CFO will attend a conference. It is an intimation or announcement about an upcoming investor meeting, not a financial report, earnings release, or detailed presentation. The document is short (1501 characters) and serves as a notification under SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-11-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of a conference call held on November 6, 2024, discussing the un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2024. It includes detailed management commentary, financial performance figures, product launches, market conditions, and Q&A with analysts. The presence of a full transcript with management discussion and Q&A clearly identifies this as a Call Transcript (CT). The document is about 15,000 characters long, contains substantive content, and is not merely an announcement or summary. Therefore, the appropriate classification is Call Transcript (CT).
2024-11-08 English
Transcript of conference call held on 6th November 2024 to discuss unaudited financial results of the Company for the quarter and half year ended on 30th September 2024
Call Transcript Classification · 100% confidence The document is a transcript of a conference call held on November 6, 2024, discussing the un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2024. It includes detailed management commentary, financial performance figures, and a Q&A session with analysts and investors. The presence of a full transcript of the earnings call, including management remarks and Q&A, clearly identifies this as a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or summary, confirming it is not an Earnings Release (ER) or Report Publication Announcement (RPA).
2024-11-08 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document is dated 7th November 2024 and is addressed to the National Stock Exchange of India and BSE Ltd, indicating a regulatory filing context. The subject clearly states it is the "Publication copy of Un-Audited Standalone & Consolidated Financial Results for the Quarter and Half-Year Ended on 30th September, 2024." This indicates it contains financial results for a quarter and half-year period, which corresponds to an Interim / Quarterly Report. The document length is 15,000 characters, which is substantial and suggests it contains actual financial data rather than just an announcement or a certification. The presence of detailed financial tables and results further supports this classification. Therefore, the document is best classified as an Interim / Quarterly Report (IR).
2024-11-07 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.